May I ask how, in your opinion, MSB should have gone about getting an appropriate historical control in a heteogeneous condition that's not particularly common and targeting a subset of that, a condition where grading and assessment have been historically subjective and unreliable?
Also, may I ask what Incyte used for their historical control that resulted in FDA approval in a similar single-arm trial?
- Forums
- ASX - By Stock
- AFR reports that the co to be sued for its promotional announcements.
MSB
mesoblast limited
Add to My Watchlist
4.39%
!
$1.85

May I ask how, in your opinion, MSB should have gone about...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.85 |
Change
-0.085(4.39%) |
Mkt cap ! $2.360B |
Open | High | Low | Value | Volume |
$1.92 | $1.93 | $1.83 | $8.270M | 4.410M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 5353 | $1.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.85 | 23082 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 41533 | 1.845 |
18 | 32270 | 1.840 |
13 | 160882 | 1.835 |
16 | 92459 | 1.830 |
8 | 49269 | 1.825 |
Price($) | Vol. | No. |
---|---|---|
1.850 | 17636 | 11 |
1.855 | 23890 | 14 |
1.860 | 39456 | 8 |
1.865 | 37622 | 11 |
1.870 | 53729 | 10 |
Last trade - 13.06pm 02/04/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
AVM
ADVANCE METALS LIMITED
Adam McKinnon, MD
Adam McKinnon
MD
SPONSORED BY The Market Online